Plain creatine monohydrate. No proprietary nootropic story.
Current evidence supports cautious interest in a possible modest memory benefit. It does not establish a general cognitive benefit, an IQ increase, disease prevention, longevity, or universal safety.
Checkout remains blocked pending independent regulatory, labeling, manufacturing, quality, and safety review.
- Ingredient
- Creatine monohydrate only
- Blend
- None
- Market
- United States only
- Status
- Product candidate, not for sale
- Batch testing
- Required before sale; no certificate published because no retail batch exists
- Personalized dosing
- Not offered
What the evidence permits us to say
Evidence and limitsmoderate
A 2024 meta-analysis found a possible modest memory benefit in adults; evidence for overall cognition and executive function was not significant.
Limit: The review included 16 trials and 492 participants; certainty was moderate for memory and low for several other cognitive outcomes.
The effects of creatine supplementation on cognitive function in adultsSafety screen before any future sale
Pregnancy, kidney disease, complex medication use, adverse symptoms, and concern about misuse trigger clinician or pharmacist guidance. Phroneme will not personalize dosing from lab data.
FDA claim boundary
Any future structure/function claim requires substantiation, FDA notification, and the required disclaimer. Disease claims remain prohibited.
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
FDA structure/function claims guidance ↗